Codiak BioSciences, Inc. Preferred Stock Dividends, Income Statement Impact
Codiak BioSciences, Inc. reported Preferred Stock Dividends, Income Statement Impact of $10.83 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2022-03-10
- Codiak BioSciences, Inc. preferred stock dividends, income statement impact for the quarter ending 2020-12-31 was $535.00K, a 84.51% decline year-over-year.
- Codiak BioSciences, Inc. preferred stock dividends, income statement impact for the quarter ending 2020-09-30 was $3.46M, a 0.09% increase year-over-year.
- Codiak BioSciences, Inc. preferred stock dividends, income statement impact for the quarter ending 2020-06-30 was $3.42M.
- Codiak BioSciences, Inc. preferred stock dividends, income statement impact for the quarter ending 2020-03-31 was $3.42M.
- Codiak BioSciences, Inc. preferred stock dividends, income statement impact for fiscal 2020 was $10.83M, a 20.95% decline from fiscal 2019.
- Codiak BioSciences, Inc. preferred stock dividends, income statement impact for fiscal 2019 was $13.70M.
| Period end | Preferred Stock Dividends, Income Statement Impact 3 month | Preferred Stock Dividends, Income Statement Impact 6 month | Preferred Stock Dividends, Income Statement Impact 9 month | Preferred Stock Dividends, Income Statement Impact 12 month |
|---|---|---|---|---|
| 2020-12-31 | $535.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $3.99M derived: sum of 2 quarters · filed 2022-03-10 | $7.41M derived: sum of 3 quarters · filed 2022-03-10 | $10.83M 10-K · filed 2022-03-10 |
| 2020-09-30 | $3.46M 10-Q · filed 2021-11-04 | $6.88M derived: sum of 2 quarters · filed 2021-11-04 | $10.30M 10-Q · filed 2021-11-04 | $13.75M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $3.42M 10-Q · filed 2021-08-05 | $6.84M 10-Q · filed 2021-08-05 | $10.29M derived: sum of 3 quarters · filed 2021-08-05 | $13.75M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $3.42M 10-Q · filed 2021-05-06 | $6.87M derived: sum of 2 quarters · filed 2021-05-06 | $10.33M derived: sum of 3 quarters · filed 2021-05-06 | |
| 2019-12-31 | $3.45M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $6.91M derived: sum of 2 quarters · filed 2021-03-17 | $13.70M 10-K · filed 2021-03-17 | |
| 2019-09-30 | $3.45M 10-Q · filed 2020-11-19 | $10.25M 10-Q · filed 2020-11-19 |